Scolaris Content Display Scolaris Content Display

The Role of rituximab for newly diagnosed, refractory or relapsed aggressive B‐cell lymphoma in adult patients

This protocol has been withdrawn

Reason for withdrawal from publication

The completion of the last task is overdue for more than one year. New authors are being sought to take over this protocol.